Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0002081169-25-000003
Filing Date
2025-08-12
Accepted
2025-08-12 17:49:57
Documents
1
Period of Report
2025-04-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1755035394.html 3  
1 FORM 3 wk-form3_1755035394.xml 3 2384
  Complete submission text file 0002081169-25-000003.txt   4125
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Issuer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 177 EAST COLORADO BLVD, SUITE 700 PASADENA CA 91105
Business Address
Apel Daniel Joseph (Reporting) CIK: 0002081169 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38042 | Film No.: 251208240